Sumitomo Pharma Co., Ltd. DNPUF
Set alert
10.50 USD -1.41 -11.84%
At close · Oct 30
10.50 Day range 10.50
8.41 52-week range 19.20
- YTD
- -26.88%
- 1 year
- -4.46%
- Open
- 10.50
- Prev close
- 11.91
- Mkt cap
- 4.71B
- Vol
- 118
- Avg vol
- 56
- EPS
- 0.68
- P/E
- 15.44
More statistics
- Low
- 10.50
- High
- 10.50
- Earnings
- Nov 4, 2026
News
4 months ago businesswire.com
Sumitomo Pharma America Achieves Key Patient Enrollment Milestone for Pivotal Phase 2 Study of Enzomenib in the Treatment of Relapsed/Refractory Acute Leukemia
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sumitomo Pharma America, Inc. (SMPA) today announced that it has enrolled the required number of participants in its pivotal Phase 2 monotherapy trial for…
8 months ago seekingalpha.com
Sumitomo Pharma Co., Ltd. (DNPUF) Discusses R&D Progress, Oncology Pipeline, and Advances in Regenerative Medicine and Vaccines Transcript
Sumitomo Pharma Co., Ltd. (DNPUF) Discusses R&D Progress, Oncology Pipeline, and Advances in Regenerative Medicine and Vaccines Transcript
8 months ago cnbc.com
Sumitomo Pharma shares plunge 12% despite greenlight for Parkinson's treatment
Shares of Japan's Sumitomo Pharma fell over 12%. Japanese government endorsed the company's iPS cell-based therapy for Parkinson's and heart disease.